<DOC>
	<DOCNO>NCT00331357</DOCNO>
	<brief_summary>The objective study describe paediatric population present acute idiopathic thrombocytopenic purpura ( ITP ) evolution therapy region Pays de la Loire . The study particularly evaluate quality life patient parent . The secondary objective identify predictive factor complication , repetition chronicity ITP , estimate principal parameter economic cost therapy child suffer ITP accord protocol therapy , set region Pays de la Loire constitution blood sample collection allow good understand physiopathology disease . It prospective , multicentric clinical epidemiologic study paediatric cohort . Patients : 100 child 0 17,99 year suffer first discover ITP . The patient include present serious , intercurrent , stabilized chronic pathology likely modify quality life child present pathology thrombopenia bring play vital prognosis within time lower one year . These patient follow 6 month accord diagnosis ITP . During 6 month follow-up patient , study carry consultation , blood test usual follow-up child suffer ITP . On hand , addition J0 questionnaire , request patient family fill questionnaires quality life way life consultation J8 , 1 month , 3 month 6 month . A check-up autoimmunity 6 month carry thrombopenia persists ( check-up usual not-specific study ) . At time blood test control platelets J0 6 month , additional blood sample carry : 5 ml take child age ≤ 2 year , 10 ml 2 4 year 15 ml blood child age &gt; 4 year . These blood sample intend constitution blood sample collection . The protocol therapy child suffer ITP homogeneous center , protocol consensus establish network Oncopaediatrics Pays de la Loire . The instituted treatment function gravity ITP express 4 stage : Stage I : Platelets &gt; 20 gigas/L absence clinical sign . Stage II : Platelets &gt; 10 gigas/L hemorrhagic sign : haematoma , petechias occasional epistaxis without repercussion daily life . Stage III : moderate . Platelets &gt; 10.000/mm3 epistaxis gauze pluggings mucous lesion . Stage IV : severe . Platelets ≤ 10.000/mm3 fall 2 grs/dl haemoglobin bleeding : epistaxis , melaena haemorrhage require blood transfusion hospitalization important change activity daily life . Stages I II receive treatment benefit simple monitoring . Stages III benefit either corticosteroid treatment ( Méthylprednisolone Prednisone ) dose 4 mg/kg per day 2 interval 4 day ( maximal dose 100 mg/day ) monitoring accord appreciation clinician . Stages IV profit first intention treatment Méthylprednisolone Prednisone dose 4 mg/kg per day 2 interval 4 day ( maximal dose 100 mg/jour ) . The therapeutic attitude stadification belong regional consensus , establish study , one decide apply treatment accord gravity clinical state child .</brief_summary>
	<brief_title>Cohort Children With Acute Immune Idiopathic Thrombocytopenic Purpura ( ITP ) : Prospective Study Pays De La Loire</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>child 0 17,99 year suffer first discover ITP serious , intercurrent , stabilized chronic pathology likely modify quality life child pathology thrombopenia bring play vital prognosis within time lower one year</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>acute idiopathic thrombocytopenic purpura</keyword>
	<keyword>paediatric</keyword>
	<keyword>quality life</keyword>
</DOC>